An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT04952064
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT04952064
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04952064. Randomized; single masking; primary purpose treatment. Start 2021-07-28 (actual); primary completion 2022-07-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Monosialoganglioside GM1
- Lead sponsor
- General Hospital of Shenyang Military Region
- Collaborator
- The Third Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct04952064- Content hash
0aba4b7fb834835d9754ceb963373b879ac4513bed3a7df4382d2d7b19a71c3e